Immune tolerance induction (ITI) according to the Bonn protocol in haemophilia A patients with inhibitors using a plasma-derived VWF-containing factor VIII concentrate: two paediatric case reports

被引：0
|
作者：
Lohse, J. [1 ]
Gehrisch, S. [1 ]
Escuriola-Ettingshausen, C. [2 ]
Kreuz, W. [2 ]
Knoefler, R. [1 ]
机构：
[1] Univ Hosp Dresden, Dresden, Germany
[2] Johann Wolfgang Goethe Univ Hosp, Frankfurt, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1073 / 1074
页数：2
相关论文
共 33 条
  • [1] Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors
    Jimenez-Yuste, V.
    Oldenburg, J.
    Rangarajan, S.
    Kurth, M. H.
    Bozzo, J.
    Santagostino, E.
    HAEMOPHILIA, 2016, 22 (01) : E71 - E74
  • [2] Rapid and sustained immune tolerance to inhibitors induced by a plasma-derived, VWF-containing FVIII concentrate
    Santagostino, Elena
    Rangarajan, Savita
    Oldenburg, Johannes
    Peiro-Jordan, Roser
    Jimenez-Yuste, Victor
    HAEMOPHILIA, 2019, 25 (02) : E110 - E113
  • [3] Case study immune-tolerance in haemophilia a using plasma-derived factor VIII concentrate
    Needham, J.
    Roy, A.
    Knight, S.
    Stebbings, Y.
    Rangarajan, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1133 - 1134
  • [4] Immune Tolerance Induction (ITI) with a Plasma-Derived Factor VIII for Patients with Hemophilia a and Inhibitors: A Retrospective Study
    Escobar, Miguel A.
    Shaffer, Linda
    Holguin, Mark
    McCavit, Timothy
    Rajan, Sandeep K.
    Amega, Novinyo
    BLOOD, 2019, 134
  • [5] Immune tolerance induction (ITI) in hemophilia A and inhibitors using VWF containing factor VIII concentrates.
    Kreuz, W
    Ettingshausen, CE
    Auerswald, GKH
    Brackmann, HH
    Klingebiel, T
    BLOOD, 2004, 104 (11) : 845A - 845A
  • [6] Switching to low dose of plasma-derived factor VIII/vWF concentrates with Confact®-F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan
    Nagao, A.
    Oka, T.
    Hanabusa, H.
    HAEMOPHILIA, 2015, 21 (05) : E425 - E427
  • [7] The use of a VWF-containing plasma-derived FVIII product in inhibitor patients likely to fail immune tolerance induction
    Kurth, M. H.
    Puetz, J.
    Kouides, P.
    Sanders, J.
    Sexauer, C.
    Berstein, J.
    Gruppo, R.
    Manco-Johnson, M.
    Neufeld, E.
    Quon, D.
    Rodriguez, N.
    WIcklund, B.
    Aledort, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 103 - 103
  • [8] Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate
    Oldenburg, J.
    Jimenez-Yuste, V.
    Peiro-Jordan, R.
    Aledort, L. M.
    Santagostino, E.
    HAEMOPHILIA, 2014, 20 (01) : 83 - 91
  • [9] Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors
    Unuvar, A
    Warrier, I
    Lusher, JM
    HAEMOPHILIA, 2000, 6 (03) : 150 - 157
  • [10] IMMUNE TOLERANCE INDUCTION (ITI) WITH A SINGLE FACTOR VIII/VON WILLEBRAND FACTOR CONCENTRATE IN HAEMOPHILIA A PATIENTS WITH INHIBITORS - DATA FROM THE OBSITI STUDY
    Escuriola-Ettingshausen, C.
    HAEMOPHILIA, 2020, 26 : 62 - 63
1234